Last reviewed · How we verify
NCT03149744
Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor
trial testing RespiraSense Sleep Screener in Respiratory Rate in 127 participants. Completed in 2 May 2017.
2 May 2017
Quick facts
| Lead sponsor | PMD Solutions |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 127 |
| Start date | 28 February 2017 |
| Primary completion | 2 May 2017 |
| Estimated completion | 2 May 2017 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- RespiraSense Sleep Screener
Conditions studied
- Respiratory Rate — all drugs for Respiratory Rate →
Sponsor
PMD Solutions
Who can join
18 and older, any sex, with Respiratory Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This investigation is looking at a currently available technology to see if it could have another use i.e. in helping to diagnose patients with sleep apnoea. With 2-4% of the population suffering from this disease, and the current wait time for a test at approximately 20 weeks, it is hoped that a simple screening method could help speed up the process of finding these patients and getting them on treatment faster. The current standard of care test involves a sleep study in the patients own home with a device with multiple parts and wires. The RespiraSense Sleep Screener is completely cableless and consists of one small, discrete unit attached to the patients side and a mobile device plugged in by the bed. Patients at Queen Alexandra Hospital who are prescribed sleep studies will be invited to participate. The RespiraSense Sleep Screener data is only for comparison purposes and will have no effect on their clinical care. If patients agree to participate they will undergo the sleep study with both devices in the same night and may be followed up with over the phone on their experiences with the test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03149744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Rate
Currently open trials in the same condition.
- NCT05451875 — Validation of Vital Signs Recording With VT-Patch Connected Devices in Children · recruiting
- NCT05022264 — Remote Investigation and Assessment of Vital Signs · recruiting
- NCT03750318 — Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital · NA · active not recruiting
Other PMD Solutions trials
Trials by the same sponsor.
- NCT03306537 — Sensor Validation Study - Quality Assurance · completed
- NCT03148873 — RespiraSense Versus Capnography & Manual Counting · completed
- NCT03752047 — Can Respiratory Rate Predict the Risk of Deterioration of Septic Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03149744 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PMD Solutions
- Last refreshed: 29 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03149744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing